Oncolytics Cash from 2010 to 2024
| ONCY Stock | USD 0.95 0.03 3.06% |
Cash | First Reported 2000-03-31 | Previous Quarter 24.9 M | Current Value 19.6 M | Quarterly Volatility 12.9 M |
Check Oncolytics Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncolytics Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 77 K, Interest Expense of 637.6 K or Selling General Administrative of 16.9 M, as well as many indicators such as Price To Sales Ratio of 66.83, Dividend Yield of 0.0 or PTB Ratio of 4.5. Oncolytics financial statements analysis is a perfect complement when working with Oncolytics Biotech Valuation or Volatility modules.
Oncolytics | Cash |
Latest Oncolytics Biotech's Cash Growth Pattern
Below is the plot of the Cash of Oncolytics Biotech over the last few years. Cash refers to the most liquid asset of Oncolytics Biotech, which is listed under current asset account on Oncolytics Biotech balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Oncolytics Biotech customers. The amounts must be unrestricted with restricted cash listed in a different Oncolytics Biotech account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Oncolytics Biotech's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncolytics Biotech's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Oncolytics Cash Regression Statistics
| Arithmetic Mean | 20,691,850 | |
| Geometric Mean | 18,040,433 | |
| Coefficient Of Variation | 50.86 | |
| Mean Deviation | 8,719,716 | |
| Median | 19,323,541 | |
| Standard Deviation | 10,524,205 | |
| Sample Variance | 110.8T | |
| Range | 36.7M | |
| R-Value | 0.27 | |
| Mean Square Error | 110.9T | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | 625,201 | |
| Total Sum of Squares | 1550.6T |
Oncolytics Cash History
Other Fundumenentals of Oncolytics Biotech
Oncolytics Biotech Cash component correlations
Click cells to compare fundamentals
About Oncolytics Biotech Financial Statements
Oncolytics Biotech investors use historical fundamental indicators, such as Oncolytics Biotech's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncolytics Biotech. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash | 34.9 M | 19.4 M | |
| Cash And Short Term Investments | 34.9 M | 26.6 M | |
| Change In Cash | 22 M | 23.1 M | |
| Free Cash Flow | -28.5 M | -27 M | |
| Begin Period Cash Flow | 9.5 M | 17.7 M | |
| Other Cashflows From Financing Activities | 781 K | 742 K | |
| Total Cash From Operating Activities | -28.4 M | -27 M | |
| Total Cash From Financing Activities | 32 M | 18.9 M | |
| End Period Cash Flow | 31.5 M | 19.3 M | |
| Total Cashflows From Investing Activities | -18.4 M | -17.4 M | |
| Other Non Cash Items | -4.9 M | -4.7 M | |
| Free Cash Flow Yield | (0.24) | (0.25) | |
| Operating Cash Flow Per Share | (0.42) | (0.44) | |
| Free Cash Flow Per Share | (0.42) | (0.44) | |
| Cash Per Share | 0.57 | 0.54 | |
| EV To Operating Cash Flow | (2.94) | (3.09) | |
| EV To Free Cash Flow | (2.94) | (3.09) | |
| Price To Operating Cash Flows Ratio | (4.15) | (4.36) | |
| Price To Free Cash Flows Ratio | (4.15) | (4.36) | |
| Cash Ratio | 8.24 | 9.50 | |
| Operating Cash Flow Sales Ratio | (6.35) | (6.67) | |
| Free Cash Flow Operating Cash Flow Ratio | 1.00 | 1.13 | |
| Cash Flow Coverage Ratios | (93.19) | (97.85) | |
| Price Cash Flow Ratio | (4.15) | (4.36) | |
| Cash Flow To Debt Ratio | (93.19) | (97.85) | |
| Cash Conversion Cycle | (490.65) | (515.19) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.